Dataset Information

Bilirubin Binding to PPAR? Inhibits Lipid Accumulation.

ABSTRACT: Numerous clinical and population studies have demonstrated that increased serum bilirubin levels protect against cardiovascular and metabolic diseases such as obesity and diabetes. Bilirubin is a potent antioxidant, and the beneficial actions of moderate increases in plasma bilirubin have been thought to be due to the antioxidant effects of this bile pigment. In the present study, we found that bilirubin has a new function as a ligand for PPAR?. We show that bilirubin can bind directly to PPAR? and increase transcriptional activity. When we compared biliverdin, the precursor to bilirubin, on PPAR? transcriptional activation to known PPAR? ligands, WY 14,643 and fenofibrate, it showed that fenofibrate and biliverdin have similar activation properties. Treatment of 3T3-L1 adipocytes with biliverdin suppressed lipid accumulation and upregulated PPAR? target genes. We treated wild-type and PPAR? KO mice on a high fat diet with fenofibrate or bilirubin for seven days and found that both signal through PPAR? dependent mechanisms. Furthermore, the effect of bilirubin on lowering glucose and reducing body fat percentage was blunted in PPAR? KO mice. These data demonstrate a new function for bilirubin as an agonist of PPAR?, which mediates the protection from adiposity afforded by moderate increases in bilirubin.

SUBMITTER: Stec DE

PROVIDER: S-EPMC4829185 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Bilirubin Binding to PPARα Inhibits Lipid Accumulation.

Stec David E DE John Kezia K Trabbic Christopher J CJ Luniwal Amarjit A Hankins Michael W MW Baum Justin J Hinds Terry D TD

PloS one 20160412 4

Numerous clinical and population studies have demonstrated that increased serum bilirubin levels protect against cardiovascular and metabolic diseases such as obesity and diabetes. Bilirubin is a potent antioxidant, and the beneficial actions of moderate increases in plasma bilirubin have been thought to be due to the antioxidant effects of this bile pigment. In the present study, we found that bilirubin has a new function as a ligand for PPARα. We show that bilirubin can bind directly to PPARα ...[more]

PMID: 27071062

Similar Datasets

Project description:PurposeBietti crystalline dystrophy (BCD) is a progressive retinal degenerative disease primarily characterized by numerous crystal-like deposits and degeneration of retinal pigment epithelium (RPE) and photoreceptor cells. CYP4V2 (cytochrome P450 family 4 subfamily V member 2) is currently the only disease-causing gene for BCD. We aimed to generate a zebrafish model to explore the functional role of CYP4V2 in the development of BCD and identify potential therapeutic targets for future studies.MethodsThe cyp4v7 and cyp4v8 (homologous genes of CYP4V2) knockout zebrafish lines were generated by CRISPR/Cas9 technology. The morphology of photoreceptor and RPE cells and the accumulation of lipid droplets in RPE cells were investigated at a series of different developmental stages through histological analysis, immunofluorescence, and lipid staining. Transcriptome analysis was performed to investigate the changes in gene expression of RPE cells during the progression of BCD.ResultsProgressive retinal degeneration including RPE atrophy and photoreceptor loss was observed in the mutant zebrafish as early as seven months after fertilization. We also observed the excessive accumulation of lipid droplets in RPE cells from three months after fertilization, which preceded the retinal degeneration by several months. Transcriptome analysis suggested that multiple metabolism pathways, especially the lipid metabolism pathways, were significantly changed in RPE cells. The down-regulation of the peroxisome proliferator-activated receptor α (PPARα) pathway was further confirmed in the mutant zebrafish and CYP4V2-knockdown human RPE-1 cells.ConclusionsOur work established an animal model that recapitulates the symptoms of BCD patients and revealed that abnormal lipid metabolism in RPE cells, probably caused by dysregulation of the PPARα pathway, might be the main and direct consequence of CYP4V2 deficiency. These findings will deepen our understanding of the pathogenesis of BCD and provide potential therapeutic approaches.

Dataset Information

Bilirubin Binding to PPAR? Inhibits Lipid Accumulation.

Publications

Bilirubin Binding to PPARα Inhibits Lipid Accumulation.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets